You should not miss this annual opportunity if you are - Chiefs, Directors, Heads, Senior Manager, Leaders and Executives from:
-
Clinical Operations
-
Clinical Developments/Research
-
Clinical Trials/ Program/ Clinical Project/Operations
-
Study and Feasibility Management
-
Medical Operations/Monitoring Operations
-
International Clinical Research
-
Patient Recruitment & Retention
-
Medical Affairs/ Medical Advisors/ MSL
-
Data Management
-
Compliance and Regulatory
-
Patient Enrolment/ Patient Advocacy/ Patient Executive
-
Therapeutic Lead
-
Study Lead/ Study Delivery/ Study Director/PI
-
Clinical Site Management
-
Digital/Medical Technologies
For group discounts and complete details contact us.
WHO SHOULD ATTEND
CONFERENCE BENEFITS
-
Get engaged with the professionals from leading industries
-
20+ Keynote Sessions
-
5+ Workshop sessions
-
Round Table Discussions – Brain storming
-
Panel Discussions – Interact Directly with the Panellists to raise your challenges
-
More than 10 Case Studies presenting by the top experts from across the industry
-
13+ hours Networking Opportunity
-
Benchmarking Opportunities
-
One-to-one interactions
-
Tea/Coffee Breaks, Social Events and Cocktail Reception
-
.…and much more!
Opportunity to meet top expert and decision makers from Pharma, Biotech, Medical Devices, Clinical Sites and CROs industry under one Roof
OVERVIEW
A rewarding opportunity to join OECT Summit in three key locations in Berlin Germany, Toronto Canada and Philadelphia USA.
OECT Summit is targeted for professionals who are always seeking for new opportunities, visionary ways of conducting performance. Study Feasibility and Patient recruitment & retention offer major challenges to the clinical researcher, clinical project managers, clinical operation managers with potential for significant impact on timelines, budgets, CRA talent rejuvenation, collaborations & partnerships and ultimately the scientific integrity of the trial itself.
Many factors affect the recruitment of patients and difficulty in finding suitable patients is driving the development of many innovative methods for accessing new patient groups. How ‘Big Data Analytics and Date Driven Decision Making’ can have a significant impact in clinical trials. The artificial intelligence, remote trials/ virtual trials, decentralised trials, connected health and digitalisation means that new technologies and changing strategies for communication can be used to engage patients at early development stage, have feasibility right at first, accelerate site selection initiation process & great effect to reach out to patients directly.
Additionally, outreach through patient advocacy groups, social service agencies are becoming more important to communicate with patients viable for trial participation as well as for those already enrolled in clinical trials. How to maximise the benefit of this approach and ensure our regulatory obligations are appropriately met will be the subject of several sessions during the summit.
Don’t forget to check our OECT Summit editions in Canada and USA.
AGENDA: TOPICS AT GLANCE
Keynote Presentation, Interactive Discussions, Case Studies, Brain Storming and Round Table Discussions
OPEX, Study Feasibility and Site Selection, Activation, Management
-
Tools to effectively plan, manage and track your clinical study portfolio
-
How to simplify CT management workflows
-
Data capture through BOYD & virtual
-
Changing roles of Clinical Project Managers
-
Study Feasibility: Right at first
-
How to use patient insights to improve clinical trial design and operations
-
Health Equity and diversity in Clinical Trials
-
Is there a need of digital enabled CRAs
-
What technologies shall sites use to meet the hybrid or virtual approach
-
DCTs – Why a way to the future
-
Remote Monitoring: Maximising the value and what does future hold
-
Biomarkers, trial, endpoints and remote monitoring tools
-
Risk Based Approach: Why change to RBM?
-
Evolution of data science in data management
-
Importance of virtual & remote trials
-
Cross Table talk between Sponsor & Sites
-
Site Inspection Readiness
-
How to have organized study programs
-
Site Selection, Activation & Management
-
Study Startup and resource allocations
-
Research-naive sites & Site staff training & motivation
-
Minimizing the unpredictable environment on budget perspective
-
Minimizing the confusions between sponsors & physicians/sites/labs
-
Digitalisation of site selection & activation
-
KPIs – Speed, Cheap & Quantity
-
Challenges in Clinical Development – Adapting into the new landscape
-
Growing SOPs complexity
-
Engagement of Investigators in Business Models or Clinical Trial protocols
-
Patient Involvement in Clinical Trial Design
PATIENT EMPOWERMENT: AS PARTER
-
Patient journey mapping
-
How to retain patients in long run trials
-
Engaging Patients in Recruitment Strategies in Clinical Trial
-
Patient awareness program
-
Holistic approach to patient recruitment
-
Patient journey mapping
-
Case Study: Oncology Trials, Rare Diseases Trials, Diabetes Trials
-
Patient Centric Approaches
-
What role sites can play in patient recruitment
-
Patient recruitment online tools
-
Demonstrating Patient Insight from an early stage of drug development
-
Advancing use of patient centric platform trials
-
Patient Recruitment in Emerging countries and Challenges for Global Trials
-
Data driven patient recruitment
CLINICAL TECHNOLOGIES & TRENDS
-
eClinical Outcome Assessments/ePRO
-
(electronic Patient-Reported Outcome) Methods
-
A hybrid model for enablement of decentralized clinical trials and remote centralized monitoring (eSource)
-
How Technology & Real-time Data Can Enable Trial Success.
-
Role of wearables, AIs, Digitalisation, eHealth in clinical innovation
-
How to translate technology/databases knowledge into identification of patients
Philippe Auby
Former CEO & President | Otsuka Europe Development & Commercialisation
Karl-Ludwig Radek
Associate Director, EMEA Strategic Account Lead, Global Clinical Operations | Janssen Cilag - Johnson & Johnsons
Emmanuel Jansa
Chief Innovation Officer | iQlinical - Accelerating Clinical Trials
Imogen Cheese
Director, Business Development | Imperial CRS
Wolfgang Summa
Head of CMO Informatics | Merck KGaA
Torsten Winkler
Managing Director, IVD, Medical Device and medical software industry | MaganaMed GmbH
Siddharth Chachad
EVP & Head – Global Clinical Management | Dr Reddys
Wolfgang Schleifer
Head Digital Delivery | Novartis
Michaela Vancova
Managing Director | Clinical Research Center(SMO)
Zina Sarif
Clinical Research Associate, Late Dev Oncology | AstraZeneca
Artem Andrianov
Managing Director and Founder | Cyntegrity
Nigel Goodman
CEO | Gaea OU
Roger Legtenberg
Senior Partner & Head of Benelux Region | Admedicum
Heike Roeder
Lead Digital Quality, Risk Advisory Life Science | Deloitte
Andrea Ochoa
Vice President Global Study Start Up | Premier Research
Tobias Kruse
Managing Director | Trials24 GmbH
Loic Notelet
Patient Engagement Lead Europe | Sanofi
Nadir Ammour
Global Lead, Clinical Innovation & Partnership | Sanofi
Marta Garcia Manrique
Chief Patient Officer | Servier
Alfred Pawson
Director Information Technology | DnA Business Consulting
Eirini Schlosser
Co-founder and CEO | Dyania Health
Richard Young
Vice President, Vault CDMS Strategy | Veeva
SPEAKERS AND PARTNERS
Well known industry leader and emerging talents
REGISTER
Basic
-
One Entry Pass to in-person Two days conference
-
Conference Material
-
Business Lunch
-
Tea and snacks
-
Cocktail Reception
Premium
-
Two Entry Passes to Two days conference and pre-conference workshop
-
One complimentary pass
-
Business Lunch
-
Tea and snacks
-
Cocktail Reception
VENUE
DoubleTree by Hilton Philadelphia – Center City
237 S Broad Street, Philadelphia, PA 1910